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Lipid analogue for study of interactions
between PIPns and proteins
Lipid molecules not only make up the cell membrane that allow for the complex
organization of life, but they are also crucial to the regulation of biological pathways.
Phosphoinositides are the most important class of lipids that control cell functions.
However, our understanding of the molecular basis for the interaction of lipids with the
proteins they regulate is still ambiguous. Such an understanding is crucial both to
conceiving the fundamental workings of living organisms and also for intervention in
disease such as cancer and diabetes that result from mis-regulating of these pathways.
The Oakley lab has therefore developed a class of lipid analogues that allow us to
display multiple copies of the polar head groups of the lipids on a spherical surface of
polymers, PAMAMTM dendrimers. To date, we have prepared two classes of dendrimers:
those modified with enantiomerically pure PI(4,5)P2 and those modified with racemic
PI(3,4,5)P3 headgroups. However, the preparation of these headgroup analogues was
found to be inefficient. This report describes progress toward a more efficient synthesis of
enantiomerically pure PI(3,4,5)P3 headgroups.
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Introduction
Interactions between lipids and proteins modulate dynamically phosphoinositide (PIPn)
signaling transductions. PIPns are essential elements in tyrosine kinase-based signaling
system and G protein receptor of signaling transductions (1 and 2). In addition, these lipid
signaling plays important roles in membrane transport and endosome activities (3),
including endocytosis, exocytosis, Golgi networks, and protein transport (4), in cell cycle
(5 and 6), in remodeling of the actin cytoskeleton (7), and in mitogenesis and oncogenesis
(8 and 9). As shown in Figure 1, PIPns are can be produced and transformed into relating
analogues within cells by the intervention of various kinases (10) and phosphatases (11).
P I P n  c a n  b e a r  v a r i o u s  h e a d g r o u p s .  L i p i d
Fig 1. Interconversions of PIPns by lipid kinases (red) Fig 2. Structures of the
phosphatidylinositol and lipid phosphatases (green). Figure taken from polyphosphates and
synthetic analogs. Figure Chem. & Biol. 11 (2004) 619-637. taken from Chem. & Biol. 11
(2004) 619-637.
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phosphatidylinositol (PI), the basic form, has no annexed phosphorylation on the inositol
ring and the other seven PIPns consist of three monophosphates, three bisphosphates, and
one trisphosphate (Figure 2).
Among these PIPns, PIP2 (PtdIns(4,5,)P2) and PIP3 (PtdIns(3,4,5)P3) play a variety of
important roles in physiological processes. PIP2 is a substrate for phospholipase C, and the
receptor-activated action of PLC on PIP2 generated the second messengers Ins(1,4,5)P3
and 1,2-diacylglycerol (DAG) (12 and 13). PIP2 has been recognized to be a crucial
element in the recruitment of signaling proteins to membranes (14), as mediated by the
pleckstrin homology (PH) domains (15). In addition, PIP2 affects the organization of the
cytoskeleton by sequestering profilin, thereby preventing the association of profilin with
monomeric F-actin and thus permitting the polymerization of actins (16). PIP2 can be
converted by agonist-stimulated, receptor–mediated activation of phosphoinositide 3-
kinase (PI 3-K) to PIP3, the key element in a new intracellular signaling system (17).
Sarah Webb and Nichole Stewart in the Oakley lab have successfully prepared of the
PAMAMTM (Aldrich) dendrimer with multiple attached PIP2 headgroups (Fig 3). These
polymers will be used to mimic PIP2 micelles as they are held in the phosphatidylcholine
bilayer, and thus should help to gain a better understanding of the orientation in which
molecule must be arranged in order to achieve binding with cytockeletal protein such as
profilin. Lewis Belcher and Nichole Stewart in the
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Fig. 3 (left): Structure of PAMAMTM dendrimer : Ethylene diamine core (green),
Generation 0 (G0) bearing 4 amine termini (red), and Generation 1 (G1) bearing 8 amine
termini (blue), (right): General scheme for attachment of phospoinositide head group to
the PAMAMTM dendrimer scaffold. Figure taken from Webb’s thesis (S.A. Webb,
Synthesis and characterization of multivalent mimics of phosphatidylinositol-4,5-
bisphosphate (PIP2) micelles, 2004.)
Oakley lab also tried to prepare racemic PIP3 by utilizing Prestwich’s synthetic route (18).
However, there are many troubles, including too low yield, tedious enantiomeric
resolution steps, and problem of acyl group migration in this synthetic route. Thus, we
have decided to adapt Bertozzi lab approach (19). – generates enantiomerically pure
inositol derivatives from C2 symmetric conduritol.
   Our ultimate objective is preparing a series of dendrimer analogues that vary in the
phosphate substitution patterns on the inositol ring and the size of the dendrimers, from
those containing 4 to 256 head groups and our short-term aim is to make PIP3 headgroup
and to establish a more efficient route for the preparation of this analogue. So, we will
monitor binding of each protein to each of the dendrimer analogue.
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Results & Discussion
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Scheme 1. (a) CH3NHOCH3·HCl, AlMe3, CH2Cl2, -10 ºC; (b) i) vinyl magnesium
bromide, THF, from -78 to -5 ºC; ii) CeCl3·7H2O, NaBH4, MeOH, -78 ºC; (c)
RuCl2CHPhPCy3IMesH2 (2 mol %), CH2Cl2, reflux; (d) PMBCl, NaH, DMF, rt; (e)
K2OsO4, K2CO3, K3Fe(CN)6, methanesulfonamide, quinuclidine, t-BuOH, H2O, rt; (f) i)
Bu2SnO, toluene, reflux; ii) allyl bromide, Bu4N+I-, 60 ºC, toluene; (g) DDQ, CH2Cl2, 0
ºC; (h) BnBr, NaH, DMF, rt; (i) 1M HCl:MeOH 1:10, rt; (j) PMBCl, NaH, DMF, rt; (k)
PdCl2, MeOH, from 0 ºC to rt; (l) i) Phosphite linker, tetrazole, CH2Cl2; ii) m-CPBA, from
-78 ºC to rt; iii) DDQ, wet CH3CN; iv) (BnO)2PNiPr2, tetrazole, CH2Cl2; v) m-CPBA,
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from -78 ºC to rt; (m) i)H2, Pd/C, ethanol; ii) Chelex column(Na+ form), Et3NH+HCO3-
(TEAB) buffer, pH 8.3
Among the headgroups of PIPns, we first have been synthesizing an analogue of
PIP(3,4,5)3. A number of strategies for the synthesis of analogues of PIP3 have been
reported in the literature (20, 21 and 22). However, there are still the difficulties in
synthesizing a selectively protected myo-inositol unit. Because myo-Inositol unit’s  chiral
centers frequently require tedious resolution steps (23) and protections of their numerous
hydroxyl groups make synthetic route longer and low yielding (24 and 25). As Ferrier
rearrangement, pinacol coupling, and ring-closing metathesis methods (26, 27, 28, 29, 30,
and 31) have been reported, the myo-inositol residue can be easily prepared from
intermediates with the appropriate stereogenic centers.
In the work described here, we have adapted Bertozzi’s synthetic route of
differentially protected myo-inositol derivatives for the production of an enanthiomerically
pure, tetherable PIP3 analogue (19) (Scheme 1). Her synthetic route has a significant
property, C2 symmetry. It gave us some merits such as no resolution step and no loss in
yield due to the formation of diastereomers. We are directly following her only through
compound 7. After this, we will modify the PIP3 analog with an aminopropyl tether at C1
position in order to serve as a bridge between PIP3 analog and PAMAMTM dendrimer.
To date, we have synthesized product 9. Weinreb amide 2 was easily synthesized in
high yield by conversion of commercially available dimethyl 2,3-O-isopropylidene-D-
tartrate. After Grignard reaction via vinyl magnesium bromide, Luche reduction gave the
1,7-diene 3. However, yield of this method of set of reactions was too low (< 10 %) in
comparison to yield (73 %) of literature. We found a possible cause that work up with
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aqueous NH4Cl or dilute HCl solution can produce Michael adduct rather than diene. As
shown in Fig 4, the liberated N,O-dimethylhydroxylamine added to the newly formed ???-
unsaturated ketone to afford Michael adduct (32). To remedy the
Fig 4. Mechanism of Michael reaction in Weinreb amide. Figure taken from A. Gomtsyan,
Org. Lett. 2 (2002), 11-13.
unfavorable situation, we needed a solution to inactivate the expelled N,O-
dimethylhydroxylamine. According to Miller’s method (he had the same trouble we had
with Grignard reaction) (33), quenching the reaction with acetic anhydride and methanol
provided the desired diene 3 in better yield (26.8 %). This reaction route is still a
challenging problem. Presumably, the other cause for low yield lies on variation of ratio of
diastereomers depending on reduction conditions. Through Grubbs' second-generation
catalyst, ring-closing metathesis afford to conduritol analog 4 in good yield. By utilizing
benzyltrietylammonium chloride as phase transfer catalyst, simultaneous PMB protection
of the C3 and C6 hydroxyl groups afforded compound 5 in low yield (10~50 %). Instead
of this method in her paper, we synthesized product 5 in higher yield (83.5 %) by sodium
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hydride as a base. Subsequent dihydroxylation (syn-addition) furnished the both
oxygenated myo-inositol intermediate 6. In this reaction, a period of reduction by Na2SO3
was essential to increase yield. Differentiation of the vicinal diol was achieved via selective
C1 allylation to produce compound 7 with high regioselectivity (89.3 %). Selective
elimination of the C6 p-methoxybenzyl ether was achieved by treatment with DDQ to
afford compound 8. However, this reaction proceeded in poor yield (16.4 %) in the
presence of an unprotected C2 hydroxyl group. So we will try to C6 PMB deprotection in
the situation of protected C2 hydroxyl group. Dibenzyl protection of the C2 and C6
hydroxyl groups afford compound 9 by the same method of PMB protection. High yield
synthetic methods in compound 3 and 8 are needed in order to provide a more efficient
route for the preparation of PIP3 analogue.
Material & Method
General Procedure. Unless otherwise noted, all reagents were obtained from commercial
supplies and used without purification. Toluene and CH2Cl2 were distilled from CaH2, and
THF was distilled from sodium benzophenone ketyl, immediately prior to use.
Chromatography was carried out using Merk 60 Å 230-400 mesh silica gel. Components
were visualized either by ultraviolet light or ceric ammonium molybdate staining. Unless
otherwise noted, all organic layers were dried over anhydrous MgSO4, and all solvents
were removed with a rotary evaporator under reduced pressure. NMR spectra were
recorded on a 300 or 400 MHz spectrometer. Chemical shift are expressed in ppm
downfield relative to tetramethylsilane. Coupling constants, J, are listed in Hertz.
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2,2-Dimethyl-[1,3]dioxolane-4,5-dicarboxylic acid bis-(methoxy-methyl-amide) (2)
To a solution of N,O-dimethyl hydroxylamine hydrochloride (17.4g, 178.7 mmol) in
CH2Cl2 (100 mL) was added trimethylaluminum (89.4 mL, 2M in n-hexane) dropwise at 0
°C under argon. The solution was allowed to warm to room temperature. After stirring for
30 min at room temperature, the solution was cooled to -10 °C. (-)-dimethyl 2,3-
isopropylidne-D-tartrate (13.0 g, 59.6 mmol) in CH2Cl2 (50 mL) was added dropwise and
then stirred for 3 hours at -10 °C under argon. The resulting solution was quenched with
1N HCl (100 mL) and then extracted with CH2Cl2 (3 X 80 mL). The organic layer was
dried over anhydrous MgSO4 and concentrated under reduced pressure. The crude
material was purified by flash chromatography (acetone : chloroform = 5 : 95) to afford
compound 2 as a white solid (11.1 g, 85.6 %). 1H NMR (CDCl3, 300 MHz): ? 5.15 (s,
2H), 3.67 (s, 6 H), 3.20 (s, 6 H), 1.49 (s, 6H). The 1H NMR data are in accord with those
previously reported.
N
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O
O
O
O
2 3
i) Vinylmagnesium bromide, THF
ii) CeCl3 . H2O, NaBH4, MeOH O
O
OH
HO
1-[5-(1-Hydroxy-allyl)-2,2-dimethyl-[1,3]dioxolan-4-yl]-prop-2-en-1-ol (3)
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To a solution of bis-Weinreb amide 2 (5.0 g, 18.1 mmol) in 80 mL of THF at -78 °C was
added vinyl magnesium bromide (54.3 mL, 1M in THF) under argon. After stirring for 30
minutes, the solution was warmed to 0 °C and then stirred for 1 hour at the same
temperature. Acetic anhydride (30 mL) was added to the solution and then it was followed
by methanol (30 mL) at 0 °C. The resulting solution was reduced to 1/4 of its original
volume under reduced pressure and then diluted with diethyl ether. The mixture was
washed with saturated NH4Cl (1 X 100 mL) and dried over anhydrous MgSO4. The
mixture was filtered and concentrated under reduced pressure. To the previous mixture in
MeOH (100 mL) was added cerium (III) chloride heptahydrate (20.2 g, 54.3 mmol). After
stirring until cerium (III) chloride heptahydrate was dissolved, the solution was cooled to -
78 °C. Sodium borohydride (2.1 g, 54.3 mmol) was added to the solution in small portion
at -78 °C. After stirring for 1h, the solution was quenched with saturated NH4Cl (50 mL),
extracted with EtOAC (3 X 50 mL), and dried over MgSO4. Flash chromatography
(EtOAC : n-hexane = 1 : 2) furnished compound 3 as a pale yellow oil (1.04 g, 26.8 %).
1H NMR (CDCl3, 300 MHz): ? 5.87 (ddd, J = 17.2, 10.4, 4.8 Hz, 2H), 5.36 (dt, J = 17.2,
1.3 Hz, 2H), 5.25 (dd, J = 10.4, 1.2 Hz, 2H), 4.14-4.10 (m, 2H), 3.99 (dd, J = 2.5, 1.3
Hz, 2H), 2.31 (d, J = 7.0 Hz, 2H), 1.43 (s, 6H). The 1H NMR data are in accord with
those previously reported.
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RuCl2CHPhPCy3IMesH2
           DCM, reflux
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2,2-Dimethyl-3a,4,7,7a-tetrahydro-benzo[1,3]dioxole-4,7-diol (4)
To the compound 3 (822 mg, 3.84 mmol) in CH2Cl2 (50 mL) was added Grubb’s second
generation catalyst, RuCl2CHPhPCy3IMesH2, (65.2 mg, 0.077 mmol). The resulting
solution was heated at reflux for 4 h and dried under reduced pressure. The crude product
was purified by flash chromatography (EtOAC : n-hexane = 2 : 1) to afford compound 4
as a colorless oil (506 mg, 70.8 %). 1H NMR (CDCl3, 300 MHz): 5.64 (s, 2H), 4.47 (s,
2H), 3.51 (dd, J = 5.6, 2.3 Hz, 2 H), 2.61 (s, 2H), 1.44 (s, 6H). The 1H NMR data are in
accord with those previously reported.
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       DMF
4 5
4,7-Bis-(4-methoxy-benzyloxy)-2,2-dimethyl-3a,4,7,7a-tetrahydro-benzo[1,3]
dioxole (5)
To a solution of conduritol 5 (560 mg, 3.06 mmol) in DMF (30 mL) was added 60 %
dispersion sodium hydride (144 mg, 6.1 mmol). After the solution was cooled to 0 °C, 4-
methoxybenzyl chloride (1.05 mL, 7.64 mmol) was added. The solution was stirred for 20
h at room temperature under argon. The solution was quenched with water and extracted
with CH2Cl2 (3 X 15 mL). The organic layer was dried over anhydrous MgSO4 and
concentrated under reduced pressure. The crude material was purified by flash
chromatography (EtOAC : n-hexane = 1 : 4) to give compound 5 as a yellow solid (1.09
g, 83.5 %). 1H NMR (CDCl3, 400 MHz): ? 7.28 (d, J = 7.1 Hz, 4 H), 6.86 (d, J = 7.1 Hz,
4 H), 5.64 (s, 2H), 4.74 (d, A of AB, JAB = 11.4 Hz, 2H), 4.58 (d, B of AB, JAB = 11.4 Hz,
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2H), 4.21(d, J = 5.9 Hz, 2 H), 3.78 (s, 6H), 3.61 (dd, J = 5.7, 1.8 Hz, 2H), 1.47 (s, 6H).
The 1H NMR data are in accord with those previously reported.
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K2OsO4, K2CO3, K3Fe(CN)6, methanesulfonamide
                  quinuclidine, t - BuOH, H2O
4,7-Bis-(4-methoxy-benzyloxy)-2,2-dimethyl-hexahydro-benzo[1,3]dioxole-5,6-diol
(6)
A solution of potassium ferrous cyanide (540 mg, 1.64 mmol), potassium carbonate (227
mg, 16.4mmol), methanesulfonamide (4.5 mg, 0.47 mmol), and quinuclidine (5.2 mg,
0.047 mmol) in water (2 mL) was stirred until it became homogeneous. Compound 5 (100
mg, 0.23 mmol) in tert-buthanol (3 mL) was added and followed by potassium osmate
dehydrate (4.3 mg, 0.012 mmol). The mixture was stirred for 24 h at room temperature.
The reaction mixture was quenched with saturated aqueous Na2SO3 (10 mL) and
extracted with EtOAC (3 X 10 mL), washed with saturated aqueous NaCl, filtered, dried
and concentrated. Flash chromatography (EtOAC : n-hexane = 1 : 1) furnished compound
6 as a white solid (79 mg, 74.6 %). 1H NMR (CDCl3, 400 MHz): ? 7.29 (d, J = 8.6 Hz, 4
H), 6.86 (d, J = 8.6 Hz, 4 H), 4.85 (d, A of AB, JAB = 11.5 Hz, 1H), 4.77 (d, B of AB, JAB
= 11.5 Hz, 1H), 4.62 (d, A of AB, JAB = 2.6 Hz, 1H), 4.59 (d, B of AB, JAB = 2.6 Hz, 1H),
4.16 (t, J = 2.6 Hz, 1H), 4.00 (t, J = 9.7 Hz, 1H), 3.79 (s, 3H), 3.78 (s, 3H), 3.77 (t, J =
9.5 Hz, 1H), 3.56 (dd, J = 10.1, 3.1 Hz, 1H), 3.50 (dd, J =12.1, 4.8 Hz, 1H), 3.35 (t, J =
9.6 Hz, 1H), 2.55-2.53 (m, 2H), 1.47 (s, 3H), 1.45 (s, 3H). The 1H NMR data are in
accord with those previously reported.
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i) Bu2SnO, toluene, refulx
ii) allyl bromide, Bu4N+I-
6-Allyloxy-4,7-bis-(4-methoxy-benzyloxy)-2,2-dimethyl-hexahydro-benzo[1,3]dioxol-
5-ol (7)
A solution of diol 6 (100 mg, 0.22 mmol) and dibutyltin oxide (54.1 mg, 0.22 mmol) in
toluene (10 mL) was heated at reflux for 3 hours with azeotropic removal of water under
argon. The solution was then cooled to 60 °C, and tert-butyl ammonium iodide (80.2 mg,
0.22 mmol) and allyl bromide (0.19 mL, 2.2 mmol) were added. The solution was stirred
for 24 h at 60 °C under argon and concentrated under reduced pressure. The crude
product was purified with flash chromatography (EtOAC : n-hexane = 1 : 2) to give
compound 7 as a pale red oil (97 mg, 89.3 %) 1H NMR (CDCl3, 400 MHz): ? 7.28 (d, J =
8.6 Hz, 4 H), 6.85 (d, J = 8.6 Hz, 4 H), 5.93-5.85 (m, 1H), 5.24 (d, J = 17.4 Hz, 1H),
5.15 (d, J = 10.0 Hz, 1H), 4.79 (d, A of AB, JAB = 8.0 Hz, 1H), 4.76 (d, B of AB, JAB =
8.0 Hz, 1H), 4.66 (d, A of AB, JAB = 11.8 Hz, 1H), 4.63 (d, B of AB, JAB = 11.8 Hz, 1H),
4.21-4.11 (m, 3H), 4.04 (t, J = 9.6 Hz, 1H), 3.89 (t, J = 8.4 Hz, 1H), 3.79 (s, 3H), 3.78
(s, 3H), 3.52 (dd, J = 10.4, 3.2 Hz, 1H), 3.36-3.26 (m, 2H), 2.58 (s, 1H), 1.46 (s, 3H),
1.44 (s, 3H). The 1H NMR data are in accord with those previously reported.
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5-Allyloxy-7-(4-methoxy-benzyloxy)-2,2-dimethyl-hexahydro-benzo[1,3]dioxole-4,6-
diol (8)
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A solution of compound 7 (80 mg, 0.16 mmol) and 2,3-dichloro-5,6-dicyano-1,4-
benzoquinone (DDQ) (43.5 mg, 0.19 mmol) in CH2Cl2 (30 mL) was stirred at 0 °C for 24
h under argon. The resulting solution was quenched with saturated aqueous NaHCO3 (20
mL) and washed saturated aqueous NaCl (1 X 20 mL), dried over MgSO4, filtered, and
concentrated under reduced pressure. Flash chromatography (EtOAC : n-hexane = 1 : 1)
afforded compound 8 as a white solid (10 mg, 16.4 %). 1H NMR (CDCl3, 400 MHz): ?
7.30 (d, J = 7.6 Hz, 2 H), 6.87 (d, J = 8.0 Hz, 2 H), 5.94-5.87 (m, 1H), 5.28 (d, J = 17.6
Hz, 1H), 5.21 (d, J = 10.0 Hz, 1H), 4.79 (d, A of AB, JAB = 11.6 Hz, 1H), 4.63 (d, B of
AB, JAB = 11.6 Hz, 1H), 4.19 (dd, J = 16.8, 9.2 Hz, 2H), 4.09-4.03 (m, 3H), 3.79 (s, 3H),
3.56 (d, J = 9.6 Hz, 1H), 3.31 (t, J = 9.4 Hz, 1H), 3.18 (d, J = 8.4 Hz, 1H), 2.47 (s, 2H),
1.46 (s, 6H).
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BnBr, NaH
      DMF
5-Allyloxy-4,6-bis-benzyloxy-7-(4-methoxy-benzyloxy)-2,2-dimethyl-hexahydro-
benzo[1,3]dioxole (9)
To a solution of compound 8 (35 mg, 0.092 mmol) in DMF (10 mL) was added 60 %
dispersion sodium hydride (4.42 mg, 0.18 mmol). After the solution was cooled to 0 °C,
benzyl bromide (0.028 mL, 0.23 mmol) was added. The solution was stirred for 24 h at
room temperature under argon. The solution was quenched with water and extracted with
CH2Cl2 (3 X 10 mL). The organic layer was dried over anhydrous MgSO4 and
concentrated under reduced pressure. The crude product was purified by flash
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chromatography (EtOAC : n-hexane = 1 : 4) to give compound 9 as a brown oil (3.86 m
g, 74.8 %). 1H NMR (CDCl3, 400 MHz): ? 7.36 (d, J = 6.4 Hz, 4 H), 7.30 (d, J = 6.8 Hz,
4 H), 7.23 (d, J = 8.4 Hz, 2 H), 6.84 (d, J = 8.8 Hz, 2 H), 5.89 -5.81 (m, 1H), 5.24 (d, J =
17.2 Hz, 1H), 5.12 (d, J = 10.8 Hz, 1H), 4.87-4.66 (m, 5H), 4.53 (d, J = 11.6 Hz, 1H),
4.12-3.95 (m, 5H), 3.77 (s, 3H), 3.50 (d, J = 10.0 Hz, 1H), 3.33 (t, J = 9.2 Hz, 1H), 3.26
(d, J = 8.8 Hz, 1H), 1.43 (s, 3H), 1.41 (s, 3H).
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